The global electrocardiography (ECG) telemetry devices market is anticipated to grow at a CAGR of 5.6% during the forecast period (2023-2030). ECG telemetry devices are essential for cardiac monitoring, diagnosing and managing arrhythmias, screening for heart conditions, enabling remote patient monitoring in telemedicine and telehealth services, postoperative care, and long-term studies. They are additionally used in clinical trials, long-term studies, sports and fitness monitoring, and consumer wearables. These devices help healthcare professionals prescribe appropriate treatment, screen individuals at risk for heart disease, and provide real-time data for assessment, consultation, and follow-up. They are additionally increasingly used in sports and fitness monitoring. Furthermore, the market’s growth is attributed to the increasing prevalence of cardiovascular disease across the globe. Cardiovascular diseases continue to be a primary cause of death globally. The increased prevalence of heart-related illnesses needs improved monitoring solutions that has been propelling the ECG telemetry devices market forward. For instance, in May 2023, Vivalink, Released 14-Day Live Stream Wearable ECG Patch for Ambulatory Cardiac Monitoring. It can be conducted with a single patch application, minimizing both physician and patient load. Furthermore, the real-time streaming features allow practitioners to view a patient's live ECG from anywhere at any time.
Browse the full report description of “Electrocardiography (ECG) Telemetry Devices Market Size, Share & Trends Analysis Report by Technology (Single Stage and Double Stage), by Absorber Type (Lithium Bromide and Ammonia), by Power Source (Direct Fired, Indirect Fired, and Water Driven), and by Application (Chemicals, Food & Beverages, Power, Paper & Pulp, power & energy and Others), Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/electrocardiography-ecg-telemetry-devices-market
Furthermore, increased cardiovascular disease burden are the major cause of death globally. The rising prevalence of heart-related diseases drives the demand for effective monitoring systems that assists the ECG telemetry devices market. in April 2022,Zoll Medical Corp launched Zoll Arrhythmia Management System (AMS), a mobile cardiac telemetry (MCT) solution that adds biometric data to traditional MCT data to help physicians make more informed treatment plans. Zoll AMS enhances the ECG information offered by standard MCT devices with biometric data (heart rate, activity, respiration rate, and body posture).
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Product
o By Application
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes BIOTRONIK SE & Co KG, GE HealthCare Technologies Inc., Hill-Rom HoldingsInc., Philips International B.V., SCHILLER AG, and others.
Key questions addressed by the report
Global Electrocardiography (ECG) Telemetry Devices Market Report Segment
By Technology
By Application
By End-User
Global Electrocardiography (ECG) Telemetry Devices Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/electrocardiography-ecg-telemetry-devices-market